Related Experiment Videos

Unveiling meropenem-induced thrombocytopenia: Insight from a positive rechallenge case

Mahdi Aleid1, Fatimah Alsaif1, Ahmed Alkudaimi1

  • 1Department of pharmacy, Mouwasat Hospital, Qatif, Saudi Arabia.

Idcases
|July 28, 2026
PubMed

Insights

Meropenem, a common antibiotic, can rarely cause drug-induced thrombocytopenia (DITP). This case highlights the importance of recognizing and stopping meropenem promptly if DITP occurs, as platelet counts recovered after discontinuation.

Area of Science:

  • Pharmacology
  • Hematology
  • Infectious Diseases

Background:

  • Meropenem is a broad-spectrum carbapenem antibiotic.
  • Drug-induced thrombocytopenia (DITP) is a rare but serious adverse effect.
  • Prompt recognition and management of DITP are crucial.
Keywords:
InfectionsMeropenemRechallengeThrombocytopenia

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...